CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Ye Weiguo Chief Operating Officer | Option exercise | +12,820 | $0.75 | $10K | 712,820 |
| 2026-05-21 | Ye Weiguo Chief Operating Officer | Sale | −12,820 | $6.15 | $79K | 700,000 |
| 2026-05-21 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −12,820 | 904,895 | ||
| 2026-05-20 | Ye Weiguo Chief Operating Officer | Option exercise | +9,400 | $0.75 | $7K | 709,400 |
| 2026-05-20 | Ye Weiguo Chief Operating Officer | Sale | −9,400 | $6.15 | $58K | 700,000 |
| 2026-05-20 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −9,400 | 917,715 | ||
| 2026-05-19 | Ye Weiguo Chief Operating Officer | Option exercise | +9,120 | $0.75 | $7K | 709,120 |
| 2026-05-19 | Ye Weiguo Chief Operating Officer | Sale | −9,120 | $6.37 | $58K | 700,000 |
| 2026-05-19 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −9,120 | 927,115 | ||
| 2026-05-18 | Ye Weiguo Chief Operating Officer | Option exercise | +200 | $0.75 | $150 | 700,200 |
| 2026-05-18 | Ye Weiguo Chief Operating Officer | Sale | −200 | $6.62 | $1K | 700,000 |
| 2026-05-18 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −200 | 936,235 | ||
| 2026-05-15 | Ye Weiguo Chief Operating Officer | Option exercise | +13,100 | $0.75 | $10K | 713,100 |
| 2026-05-15 | Ye Weiguo Chief Operating Officer | Sale | −13,100 | $6.65 | $87K | 700,000 |
| 2026-05-15 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −13,100 | 936,435 | ||
| 2026-05-14 | Zhang Ping Director | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | ||
| 2026-05-14 | Ye Weiguo Chief Operating Officer | Option exercise | +15,580 | $0.75 | $12K | 715,580 |
| 2026-05-14 | Ye Weiguo Chief Operating Officer | Sale | −15,580 | $6.91 | $108K | 700,000 |
| 2026-05-14 | Ye Weiguo Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −15,580 | 949,535 | ||
| 2026-05-06 | Luo Ying Chief Executive Officer | Sale 10b5-1 | −10,136 | $8.04 | $81K | 2,565,226 |
Page 3 of 11 · 215 trades